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This study aimed to elucidate associations between stroke onset and severity as well as
chronotype (phase of entrainment) and internal time of stroke. Fifty-six first-ever ischemic
stroke patients participated in a cross-sectional study assessing chronotype (mid-sleep on
work-free days corrected for sleep deficit on workdays; MSFsc) by applying the Munich
ChronoType Questionnaire (MCTQ).The MCTQ was completed twice, on average 68± 24
(SD) days post stroke and retrospectively for the time before stroke. To assess the impact
of stroke in relation to internal time, InTstroke was calculated as MSFsc minus local time
of stroke. Stroke severity was assessed via the standard clinical National Institute Health
Stroke Scale (NIHSS) and modified Ranking Scale (mRS), both at hospital admission and
discharge. Overall, most strokes occurred between noon and midnight. There was no sig-
nificant association between MSFsc and stroke onset. MSFsc changed significantly after
stroke, especially in patients with more severe strokes. Changes in MSFsc varied with
InTstroke – the earlier the internal time of a stroke relative to MSFsc-before-stroke, the more
MSFsc advanced after stroke. In addition, we provide first evidence that MSFsc changes
varied between stroke locations. Larger trials are needed to confirm these findings.
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INTRODUCTION
The onset of vascular events exhibits a circadian (about 24-h)
pattern, with a prominent peak in the morning hours and a
second, smaller peak in the early evening (1–4). This phenom-
enon is thought being caused by diurnal variations in underlying
pathophysiological mechanisms, e.g., platelet aggregation, blood
pressure, and catecholamine concentrations (3, 5). Several animal
studies demonstrated that cerebrovascular events, in turn, also
impact circadian rhythms and sleep architecture (6–9). Longer
latencies to fall asleep, fragmented sleep, NREM sleep instabil-
ity, and hypersomnia have also been described in stroke patients,
indicating changes in sleep homeostasis and circadian rhythmicity
after stroke (10, 11). Two studies with small sample sizes provided
some evidence of altered timing in urinary melatonin as a marker
of disturbed circadian rhythms in stroke patients (12, 13). How-
ever, knowledge on the interplay between sleep homeostasis, the
circadian timing of sleep, and vascular events is still incomplete.
The circadian timing of sleep is regulated by an internal clock,
which is synchronized (entrained) by light to the 24-h day (14,
15). The relation between external (local) and internal (circadian)
time is called phase of entrainment (16) and people that differ
in this trait are referred to as different chronotypes. Chronotype
can easily be assessed with the Munich ChronoType Questionnaire
[MCTQ; (16)] as the mid-point of sleep on work-free days (MSF),
corrected for sleep deficit accumulated across the workweek (MSF
sleep corrected; MSFsc). MSFsc as a measure for internal time
allows calculating the internal time point of a physiological event
(17, 18). Social jetlag (the difference between MSF and mid-sleep
on workdays, MSW) is a surrogate measure for circadian rhythm
disruption and has been linked to elevated heart rate in shift-
workers (19), smoking (20), and depression (21). To date, no study
has assessed phase of entrainment (chronotype) and social jetlag
before and after stroke to compare the impact of stroke in relation
to internal time.
The current study was the first to investigate associations
between stroke onset and severity and internal time before and
after stroke. We hypothesized that (a) there is a correlation between
chronotype (MSFsc) and stroke onset, (b) experiencing a stroke
results in chronotype changes, and (c) the impact of stroke varies
with the internal time point a stroke happened.
MATERIALS AND METHODS
Between October 2011 and March 2012, 197 consecutive patients
treated at the Charité University Hospital Berlin, Germany, who
had suffered from first-ever ischemic stroke in the previous
3 months were invited by mail to participate in a cross-sectional
assessment of sleep timing before and after stroke. The MCTQ (16)
was applied to calculate each patients’ chronotype [MSFsc, cor-
rected for sleep deficit on workdays, as MSF minus (sleep duration
on work-free days minus average sleep duration of the week)/2;
(16)] and social jetlag [difference between MSW and MSF; (20)].
Internal time point of a stroke (Intstroke) was calculated as hours
since the clock time for the mid-point of sleep on days off cor-
rected for sleep deficit on working days, from MCTQ entries for
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the time before stroke. The MCTQ was completed twice, on the
same day using the same instructions, and on average 68± 24 (SD)
days post stroke and retrospectively for the time before stroke.
Changes in chronotype were assessed as MSFsc-after-stroke minus
MSFsc-before-stroke.
Clinical information including the time point of stroke was
obtained through case report forms, discharge letters, and radio-
logical reports. For patients who were well at bedtime but woke
up with symptoms, stroke onset was defined as the time point of
awakening (5). Information on stroke severity was collected via the
National Institute Health Stroke Scale (NIHSS) (22) and modified
ranking scale (mRS) (23, 24), both at hospital admission and dis-
charge. The NIHSS quantifies stroke-related neurological deficits
including key aspects of neurological examination (e.g., motor
strength, sensation, or language function) (22, 25) and provides
a severity score ranging from 0 (indicating no symptoms) to 42.
The mRS measures functional outcomes after stroke and consists
of 5 grades with 0= no symptoms, 1= no significant disability,
despite symptoms, 2= slight disability, 3=moderate disability,
4=moderately severe disability, and 5= severe disability (24, 26).
Stroke severity was categorized (NIHSS scores at hospital admis-
sion) as mild (≤ 5; 68.6%), moderate (6 to 13; 25.7%), and severe
(≥ 14; 5.7%) (27). To assess the effects of stroke location on MSFsc,
participants were split into two groups with (i) strokes of the ante-
rior circulation providing blood to the cerebrum (middle, anterior
and posterior cerebral artery and anterior choroidal artery) and
(ii) strokes of the posterior circulation proving blood to the cere-
bellum and brain stem (ventrobasilar and vertebrobasilar artery).
Patients did not receive financial compensation for study partic-
ipation. As an incentive to participate, patients were offered an
appointment at the Center of Sleep Medicine at the Charité Uni-
versity Hospital for an individual sleep evaluation (not part of this
study). Written informed consent was obtained from each patient.
The ethics committee of the Charité University Berlin approved
the study protocol (EA1/214/11).
Data analysis was performed using IBM SPSS Statistics 20.0
for Macintosh. Parametric and non-parametric statistical analy-
ses were performed as appropriate after subjecting the data to the
Shapiro–Wilk test to verify if the data were normally distributed.
All demographic variables were expressed as mean± SD. All p val-
ues were two-tailed and statistical significance was set at a value
<0.05 applying Bonferroni correction for multiple testing.
RESULTS
The response rate was 28% (56 patients). We excluded 20 patients
due to incomplete data and one patient due to reporting to work
night shifts. For the remaining 35 patients, we were able to calcu-
late chronotype (MSFsc) both before and after stroke (Figure 1).
Baseline characteristics of the 35 patients are provided in Tables 1
and 2. Strokes occurred between July 2011 and January 2012.
Patients filled out the study questionnaires on average 68± 24
(SD) days post stroke. Mean NIHSS at hospital admission was
4.4± 4.2 and mean mRS was 2.3± 1.5. NIHSS and mRS were
significantly reduced at discharge compared to hospital admis-
sion (Table 2). Fifteen of the 35 participants received fibrinolytic
agents. We did not find significant differences between the 197 ini-
tially contacted patients and the final 35 participants regarding age,
FIGURE 1 | Study flow chart of patient enrollment and data analysis.
sex, time points of stroke, and stroke severity (data not shown).
Stroke location was only available for the final participants.
Figure 2 shows the distribution of strokes by time of day in
the 35 patients. Sixty percent of strokes occurred between noon
and midnight. The highest number of strokes was found at 8 p.m.
(14%) and the second highest number at 7 a.m. (11%). Twenty-six
percent were classified as wake up strokes.
Comparing the MCTQ entries from before and after stroke
revealed significantly longer sleep durations on workdays and
work-free days after stroke (Table 3). Chronotype (MSFsc)
changed significantly after stroke, whereas social jetlag remained
statistically unchanged (Table 3).
The time point of stroke was not associated with a patients’
MSFsc-before-stroke (R= 0.092, p= 0.607; Spearman correlation).
Since MSFsc was found to be on average significantly advanced
after stroke, we calculated the individual MSFsc differences
(MSFsc-after-stroke minus MSFsc-before-stroke) and correlated this
individual MSFsc difference with stroke severity at both hospital
admission and discharge. There was a significant negative corre-
lation between NIHSS and mRS at discharge with the difference
in chronotype after stroke (Table 4), which remained significant
after controlling for the number of days between stroke and study
participation (r =−0.565, p= 0.001 for NIHSS at discharge, and
r =−0.620, p< 0.001 for mRS at discharge; Spearman correla-
tion). These correlations indicate that patients with more severe
strokes showed more pronounced changes in their sleep timing.
Intstroke was assessed to explore associations between the inter-
nal time point of stroke (relative to an individual’s MSFsc)
and stroke severity. The closer a stroke happened to a patient’s
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Table 1 | Characteristics of all 35 stroke patients at time point of study participation/hospital admission.
ID Variable
Sex Age MSFsc Work NIHSS mRS Localization Month Full hour Dem./Depr
1 2 1 2 1 2 1 2
2 F 57 3.2 3.2 Y Y 1 1 1 1 MCA l July 20:00 No/no
3 F 69 4.2 4.0 N N 1 1 1 1 MCA r July 20:00 No/no
4a M 68 3.0 3.0 N N 4 0 3 0 MCA l, PCA l July 07:00 No/no
5 M 59 2.4 2.4 Y Y 1 0 1 0 MCA r August 20:00 No/no
7 M 58 2.1 2.5 Y Y 5 1 2 1 MCA l July 14:00 No/no
8 M 53 4.0 3.6 Y Y 2 0 1 0 MCA l August 07:00 No/no
10 M 87 2.3 1.1 Y N 6 2 3 2 MCA l July 13:00 Yes/no
11 F 79 3.5 4.0 Y Y 0 0 0 0 MCA r September 22:00 No/no
12a M 63 3.6 2.2 Y N 9 14 5 5 MCA r July 07:00 No/no
15a M 62 2.4 2.6 Y Y 8 0 5 0 Ventrobasilar July 16:00 No/no
17a M 72 2.6 2.8 N N 1 1 1 1 Ventrobasilar August 14:00 No/no
18 F 82 4.3 4.3 N N 2 2 1 1 Ventrobasilar August 17:00 No/no
19 M 54 3.3 3.3 Y Y 1 1 1 1 MCA l July 05:00 No/no
20 F 77 3.3 2.8 Y Y 6 2 3 1 MCA bs October 04:00 No/no
21a M 66 4.0 4.1 N N 16 0 5 0 MCA r October 17:00 No/no
22a F 49 4.2 3.3 Y N 3 2 2 2 MCA l September 21:00 No/no
23 M 65 1.8 1.8 Y Y 1 1 1 1 MCA r October 05:00 No/no
25 F 87 3.8 3.8 Y Y 0 0 0 0 MCA r, PCA r October 20:00 No/no
26a F 27 4.7 3.5 Y N 6 4 2 2 PCA l October 04:00 No/no
27a M 37 4.2 4.2 Y Y 1 0 1 0 Ventrobasilar September 20:00 No/no
30a M 56 2.8 3.5 Y Y 10 2 4 1 Ventrobasilar November 23:00 No/no
32 M 48 3.8 2.0 Y n/a 6 3 2 1 MCA l November 15:00 No/no
33a F 62 4.4 3.8 Y N 5 0 1 0 MCA l October 03:00 No/no
34a F 78 3.2 1.4 Y N 17 15 5 5 MCA l October 10:00 No/yes
35a M 65 2.9 3.0 Y N 8 3 4 2 AChA r November 13:00 No/yes
36 M 89 2.8 1.5 N N 11 6 4 3 MCA r, PCA r November 07:00 No/no
37a M 67 3.3 3.3 N N 2 0 1 0 MCA l, PCA l November 10:00 No/no
39 M 76 2.8 2.2 Y Y 4 2 2 2 MCA l December 10:00 No/no
42 F 69 3.8 3.8 Y Y 2 2 2 2 AChA l January 15:00 No/no
43a M 62 2.4 2.4 Y Y 4 0 4 0 Vertebrobasilar January 21:00 No/no
44 M 73 3.5 3.5 N N 1 0 1 0 MCA l, PCA January 12:00 No/no
45a F 81 5.0 3.0 N N 3 0 3 1 MCA l January 17:00 No/no
48 M 63 2.1 2.1 N N 5 1 2 1 AChA l January 06:00 No/no
49 M 73 3.8 3.7 N N 1 1 1 1 MCA r December 21:00 No/no
50a F 86 3.6 3.6 Y Y 2 0 4 1 PCA l December 19:00 No/no
Sex female, male/MSFsc (1) chronotype before (2) after stroke/Work (1) employed before (2) after stroke, yes, no/Localization= stroke localization with MCA, middle
cerebral artery, PCA, posterior cerebral artery, AChA, anterior choroidal artery with left, right, bs=both sides/Month of stroke/NIHSS/mRS (1) at hospital admission
(2) at discharge/Dementia/Depression.
apatient received a fibrinolytic agent.
MSFsc-before stroke, the larger the advance of MSFsc at 3 months
after stroke (Figure 3). This association remained significant after
using the number of days between stroke and study participa-
tion as covariate (R= 0.398, p= 0.024; Spearman correlation).
In addition, there was a significant difference in MSFsc changes
between stroke locations. Strokes that occurred in the anterior
circulation lead to delays of MSFsc, whereas strokes within the
posterior circulation lead to advances of MSFsc (Figure 4).
The standard clinical assessment at hospital admission showed
a number of risk factors and co-morbidities that were evenly dis-
tributed among the participants, including arterial hypertension,
atrial fibrillation, rheumatoid arthritis, back problems, hypercho-
lesteremia, smoking, and diabetes mellitus Type II. Medication
at discharge did not substantially vary among participants. Most
common drugs were acetylsalicylic acid, simvastatin, and ramipril
(Table 5).
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Table 2 | Characteristics of 35 (13 female) stroke patients at admission
to and discharge from hospital.
Variables At admission At discharge p-Value
Mean SD Mean SD
Age (years) 66.3 14.0 – – –
Stroke time point (h) 13.6 6.2 – –
NIHSS 4.4 4.2 1.9 3.4 <0.001a
mRS 2.3 1.5 1.1 1.3 <0.001a
aWilcoxon signed ranks test.
FIGURE 2 | Distribution of the number of strokes by time of day in 35
(13 female) stroke patients. Most strokes per hour were observed at
07:00 and 20:00 h.
DISCUSSION
Chronotype (MSFsc) and sleep duration on both workdays and
work-free days changed significantly after stroke in our group of
patients. The change in MSFsc after stroke was negatively corre-
lated with stroke severity (NIHSS and mRS at hospital discharge),
which was independent of the number of days between stroke and
study participation [on average 68± 24 (SD) days]. More pro-
nounced motor deficits in these patients leading to also less time
outdoors in sunlight could explain this finding, and physical activ-
ity has been shown to impact the circadian rest-activity system
(28). We did not observe significant associations between month
of stroke and MSFsc changes and, therefore, exclude an effect of
seasonal changes in light exposure on the observed chronotype dif-
ferences. Twenty percent of our patients reported to not continue
working after stroke, which could have impacted their sleep tim-
ing. However, patients who did not continue working after stroke
still indicated different sleep times on workdays and work-free days
in their MCTQ after stroke. This finding suggests that even in the
absence of job obligations, these patients kept their daily routines
similar to as they did before their stroke (e.g., due to early morning
rehabilitation appointments after stroke compared to early morn-
ing work schedules before stroke). We did not find significant
differences in social jetlag (a marker for displaced sleep because
of early morning obligations) at 3 months after stroke, suggesting
negligible impact on sleep from changes in working status.







Mean SD Mean SD
Sleep latency on
workdays (min)
19.0 24.3 17.0 17.5 −2.0 0.552§
Sleep onset on
workdays (h)
−0.7 0.9 −1.2 1.3 −0.5 0.011*
Sleep end on
workdays (h)
6.6 1.2 6.8 1.2 −0.2 0.197*
Sleep inertia on
workdays (min)
13.6 19.7 18.4 27.4 +4.8 0.106§
Sleep duration on
workdays (h)
7.3 1.0 8.0 1.6 +0.7 0.010*
Sleep latency on
free days (min)
19.6 24.3 15.4 16.1 −4.2 0.484§
Sleep onset on
free days (h)
−0.4 0.9 −1.0 1.3 −0.6 0.002*
Sleep end on free
days (h)
7.4 0.9 7.3 1.0 −0.1 0.558*
Sleep inertia on
free days (min)
18.8 20.3 20.2 27.8 +1.4 0.675§
Sleep duration on
free days (h)
7.7 1.1 8.3 1.5 +0.6 0.023*
Chronotype
(MSFsc, h)
3.3 0.8 3.0 0.8 −0.3 0.014*
Social jetlag (h) 0.6 0.8 0.4 0.6 −0.2 0.108§
Bold numbers indicate statistically significant differences with *paired t-test and
§Wilcoxon signed ranks test.
Animal studies have demonstrated adverse effects of stroke on
sleep architecture (6, 7, 9) and experimentally induced stroke in
animal models has been shown to destabilize circadian rhythms
as evidenced by altered timing of melatonin secretion (8). Thus,
acute lesions in the central nervous system after stroke might result
in circadian phase shifts. Changes in sleep homeostasis with pro-
longed sleep latencies, fragmented sleep pattern, and disturbed
NREM sleep were shown in human stroke patients (10, 11) and
discussed in the context of reduced subjective quality of life (29).
Here, we did not find significant changes in sleep latency in our
participants. Only few studies addressed circadian phase shifts in
human stroke patients, by assessing changes in urinary melatonin
secretion after stroke (12, 13). No studies in humans have assessed
differences in phase of entrainment as a result of stroke as we did
in the current study with the MCTQ.
Concerning stroke onset in relation to time of day, our finding
of an evening peak at 8 p.m., and a second peak at 7 a.m. is in
line with previous reports (2–5). The bimodality in the distribu-
tion of stroke onsets across the 24-h day indicates the potential
for chronotherapies tailored for more individualized medicine, as
also elaborated on previously by Manfredini and co-workers (3).
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Table 4 | Significant correlations between MCTQ entries and stroke time point with NIHSS and mRS in 35 (13 female) patients.
Variables Admission Discharge
NIHSS mRS NIHSS mRS
R p R p R p R p
∆ MSFsc (h) −0.24 0.180 −0.16 0.377 −0.38 0.031* −0.49 0.004*
∆ Sleep onset workdays (h) −0.45 0.006* −0.37 0.029* −0.39 0.020* −0.42 0.013*
∆=difference in entries to the MCTQ between before and after the stroke/*Spearman correlation.
FIGURE 3 | Correlation between Intstroke (MSFsc-before-stroke − local time
point of stroke) (x -axis) and the difference in MSFsc after stroke
(MSFsc-after stroke −MSFsc-before stroke) (y -axis) in 35 stroke patients (13
female) (Spearman correlation, R =0.421, p=0.015). The correlation
shows that the closer the time point of a stroke is to an individual’s MSFsc,
the larger the advance (expressed as positive values on the y -axis) in
chronotype (MSFsc) after the stroke.
We found no correlation between MSFsc (chronotype) and
stroke onset. Rather, the impact of stroke on MSFsc varied with
the internal time of stroke (InTstroke). This finding was inde-
pendent of the number of days between stroke onset and study
participation – the closer a stroke happened to an individual’s
MSFsc-before-stroke, the stronger the advance of MSFsc at the time
of follow-up.
In addition, we found that strokes within the anterior circu-
lation affected MSFsc significantly different compared to strokes
within the posterior circulation. Because of our small sample size,
we can only speculate on the implications of this finding. For
example, the anterior circulation supplies blood to the cerebrum,
whereas the posterior circulation provides blood to the cerebellum
and brain stem. Since the ascending arousal system (AAS) of the
brain stem (30) regulates the transitions between sleep and wake,
a stroke in the AAS, therefore, might disturb the sleep/wake switch
(31) leading to changes in sleep timing. In addition, reduced blood
flow to the cerebellum could lead to impaired locomotor activ-
ity, which, in turn, might lead to earlier sleep times. In contrast,
the anterior circulation also provides blood to the suprachias-
matic nucleus (SCN), which is key to the circadian entrainment
process (32, 33). Future studies using, for example, brain scan
techniques will help to verify if temporally reduced blood and
FIGURE 4 | Significant difference in MSFsc changes (MSFsc-after stroke −
MSFsc-before stroke) between strokes within the anterior circulation
(middle, anterior and posterior cerebral artery and anterior choroidal
artery; providing blood to the cerebrum) and strokes within the
posterior circulation (ventrobasilar and vertebrobasilar artery; proving
blood to the cerebellum and brain stem) (*p=0.016, Mann–Whitney U
test). Positive values on y -axis indicate MSFsc advances. See alsoTable 1
for stroke locations.
glucose supply to SCN neurons impacts circadian entrainment
properties in stroke patients. In addition, the SCN is intimately
connected within the central nervous system via a host of afferent
and efferent projections (34, 35). Investigations of neurological
deficits after stroke related to compromised functions of brain
structures upstream and/or downstream of the SCN are highly
warranted. The current study found delays of MSFsc in patients
with strokes that occurred early within their internal day, whereas
MSFsc rather advanced after strokes occurring at later internal
time points. Therefore, one could hypothesize that stroke vulner-
ability within blood circuits (e.g., depending on blood vessel type
or size) might vary with internal time. A time-of-day effect, for
example, of stroke severity has been shown, with strokes happen-
ing during sleep being more severe than strokes happening during
wakefulness (36).
Strength of our study is a homogenous sample of only first-ever
ischemic stroke patients. As we did not find statistically signifi-
cant differences in baseline characteristics such as age, sex, time
point of stroke, and stroke severity between study participants
and the initially contacted patients, we consider our study sam-
ple to be representative for the initial population. Limitations of
our study are the retrospective study design and a participation
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Table 5 | Medication at hospital discharge in all 35 (13 female) stroke
patients.
ID Medication name
2 Pantoprazole, dronedarone, phenprocoumon, simvastatin
3 Ramipril, clopidogrel, amlodipine, indacaterol, beclometasone
dipropionate, tiotropium bromide, atorvastatin, indapamide
4 Aspirin, dipyridamole, telmisartan, pantoprazole, allopurinol,
metoprolol succinate, fluvastatin, alfacalcidol
5 Acetylsalicylic acid
7 Clopidogrel, acetylsalicylic acid, amlodipine, bisoprolol, atorvastatin
8 Acetylsalicylic acid, simvastatin
10 Acetylsalicylic acid, simvastatin, bisoprolol, enalapril,
hydrochlorothiazide, allopurinol, levothyroxine, phenprocoumon,
tiotropium bromide, formoterol
11 Acetylsalicylic acid, simvastatin, cortison, calcium, vitamin D,
indapamide
12 Metoprolol, acetylsalicylic acid, simvastatin, dalteparin
15 Ramipril, amlodipine, doxazosin, acetylsalicylic acid, potassium citrate
17 Clopidogrel, lercanidipine, simvastatin, levothyroxine, lisinopril,
hydrochlorothiazide, allopurinol
18 Acetylsalicylic acid, simvastatin, latanoprost eye drops, bisoprolol
19 Acetylsalicylic acid, simvastatin, ramipril
20 Acetylsalicylic acid, levothyroxine, roxythromycin, lorsartan,
metoprolol succinate, spironolacton, hydrochlorothiazide, torasemide
21 Simvastatin, acetylsalicylic acid, glimepiride, metformin, verapamil,
phenprocoumon
22 Simvastatin, acetylsalicylic acid
23 Acetylsalicylic acid, ramipril, metformin, pantoprazole, simvastatin
25 Acetylsalicylic acid, simvastatin
26 Acetylsalicylic acid
27 Acetylsalicylic acid
30 Acetylsalicylic acid, simvastatin, citalopram
32 Acetylsalicylic acid, simvastatin
33 Acetylsalicylic acid, simvastatin, ramipril, pantoprazole, diclofenac
34 Ramipril, simvastatin, bisoprolol, dabigatran, fluoxetine
35 Acetylsalicylic acid, simvastatin, ramipril, amlodipine, metoprolol
succinate, citalopram
36 Acetylsalicylic acid, fraxiparin, marcumar, pravastatin, prednisolon,
molsidomin, carvedilol, ramipril, kalinor, pantozol, tamsulosin,
cefuroxim
37 Acetylsalicylic acid, metroprolol, amlodipin, brenzbromaron
39 Enalapril, marcumar, acetylsalicylic acid, fragmin P, cordarex, sortis
42 Acetylsalicylic acid, simvastatin, candesartan, timolol at
43 Acetylsalicylic acid, simvastatin
44 Acetylsalicylic acid, dabigatran, carmen, HCT, metoprolol, pantozol,
simvastatin
45 Acetylsalicylic acid, l-thyroxin, simvastatin
48 Clopidogrel, metoprolol, simvastatin, ramipril
49 Acetylsalicylic acid, simvastatin
50 Levocomp, symbicort 1 hub, bisoprolol, pantozol, novamin,
acetylsalicylic acid
rate of 28%, which was not caused by a lower stroke severity
in participants compared to non-participants. A response rate of
about 30% is, however, to our knowledge not unusual for cross-
sectional assessments by mail in clinical populations. In addition,
because 25% of the 56 initial participants expressed interest in an
individual sleep evaluation, we cannot exclude that this incentive
to participate in the study caused a selection bias in our study
population. Two of the 35 participants showed signs of depression
at hospital admission (IDs 34 and 35, Table 1), and 1 patient was
diagnosed with signs of dementia (ID 10, Table 1), which renders
these factors unlikely to influence the main outcome. However,
we did not have information about the clinical condition (e.g.,
depression status, prevalence of sleep problems) of the patients
at the time of the survey, which might have influenced our find-
ings, since depression after stroke has been shown to predict sleep
disturbances (37). Since it is impossible to know the occurrence
of a stroke beforehand, prospective studies following people at
high risk for vascular events should include both assessments of
external (local) and internal (biological) time. Post hoc power and
sample size calculations performed using SAS JMP 7.0 software
showed a statistical power of 58% of the current data set with 58
participants needed to obtain a statistical power of 80%.
In conclusion, this is the first study that provides evidence for
changes in chronotype (MSFsc) at up to 3 months after stroke,
which were associated with both stroke severity and the internal
time point at which a stroke occurred. We did not find a signifi-
cant association between stroke onset and MSFsc. Future studies
are needed to scrutinize our findings in larger samples with also
applying daily sleep diaries and objective measures (e.g., actigra-
phy or melatonin samples) to better quantify the circadian impact
of stroke. We hope that our findings provide sufficient evidence to
stimulate larger follow-up studies expanding to also other vascular
and cardiac events like hemorrhagic strokes, heart attacks, atrial
fibrillation, or pulmonary embolism.
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